Prostate Cancer—Treatment Do’s and Don’ts
March 11, 2009 by Bob Livingston
Men who have prostate cancer have autoimmune disease. This means that the body begins to view the prostate as foreign and so the body attacks its own prostate. The prostate specific antigen (PSA) test reveals this self attack or malfunction of nature.
The Random House Unabridged Dictionary (2nd Edition, 1993) defines autoimmune disease as “a disease resulting from a disordered immune reaction in which antibodies are produced against one’s own tissues, as systemic lupus, erythematosus, rheumatoid arthritis.” And we add BPH, or benign prostate hypertrophy, possibly leading to prostate cancer.
These are inflammatory diseases and doctors usually treat with immunosuppressive drugs and steroids, and yes, surgery.
So what do we “rational beings” do? Our immune system attacks our prostate and so we attack the prostate also with surgery, radium, androgen-blockage, etc. Yes, medical orthodoxy blocks testosterone production. This is in every way against prostate and cardiovascular health.
It is not our prostate’s fault so why make all out war on it?
Royal Lee, M.D., developed a product that he named Prostate Protomorphogen or Prostate product PMG. This is a uniquely formulated nucleoprotein-mineral that promotes healthy cellular division, function and growth. This product does not attack the prostate but neutralizes the attacking antibodies.
This is not a nutritional product. Its designed function is to stop the immune antibodies from attacking the prostate thereby lowering the PSA.
However the prostate does need specific nutrition such as Cataplex F, Zinc Liver Chelate, Calcium Lactate and Organic Iodine.
Vitamin D protects against prostate cancer. In one study involving 1,029 men with prostate cancer, researchers analyzed the men’s blood looking for several factors including levels of vitamin D. They found that the men with the highest levels of vitamin D had significantly lower overall risk (45 percent) of prostate cancer, including aggressive prostate cancer.